We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04590963
Brief Title: Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer (INTERLINK-1)

First Submitted : September 23, 2020
First Submitted that Met QC Criteria : October 12, 2020
First Posted : October 19, 2020

Last Update Submitted that Met QC Criteria : August 26, 2022
Last Update Posted : August 29, 2022